Parabon NanoLabs designs and develops a new class of therapeutics and other
products made possible by proprietary technology for precisely directing the
self-assembly of designer macromolecules that are functionalized with molecular
subcomponents (e.g., enzymes, metals or pharmaceuticals). Our nanoscale development
platform gives our scientists the ability to design and construct multi-functional
macromolecules from simpler subcomponents, replacing the current paradigm of
"molecular discovery" with that of "molecular design."
Parabon NanoLabs is currently designing macromolecules for use in the areas
of cancer therapeutics, nano-scale sensors for bioweapons defense, and nanoarrays
for rapid readouts of DNA.